Skip to main content
. 2024 Mar 2;12(3):52. doi: 10.3390/diseases12030052

Table 4.

(a) Characteristics of patients with ESCPM BSIs and (b) characteristics of patients with ESBL BSIs.

(a)
Patient Sex Age (years) Number of Comorbidities ESCPM Species ESBL Suspected Site Associated witd BSI Healthcare-Associated Infection qPitt Score for Severity Initial Empirical Therapy according to AST Clinical Stability after 48 h Delay Until Reassessment of Therapy in Case of Switch (days) In-Hospital Death
1 M 65 2 Enterobacter cloacae Yes Urinary No 0 Effective Yes No change No
2 M 69 2 Enterobacter cloacae No Gastrointestinal No 0 Ineffective Yes 5 No
3 F 77 3 Klebsiella aerogenes No Vascular No 0 Ineffective No 3 No
4 M 72 2 Enterobacter cloacae No Pulmonary Yes 2 Ineffective Yes No change Yes
5 M 88 4 Enterobacter cloacae Yes Urinary No 0 Ineffective No 5 No
6 F 69 1 Enterobacter cloacae No Gastrointestinal No 1 Ineffective No No change Yes
7 M 89 2 Enterobacter cloacae Yes Vascular Yes 0 Effective Yes 2 No
8 F 70 1 Enterobacter cloacae No Gastrointestinal No 2 Effective Yes No change No
9 M 58 1 Enterobacter cloacae No Gastrointestinal No 0 Ineffective Yes 1 No
10 M 56 1 Providencia stuartii No Urinary No 2 Ineffective No 3 No
11 F 85 2 Morganella morgnaii No Urinary No 0 Effective Yes No change No
12 F 85 3 Pantoea agglomerans No Vascular No 0 Effective No 2 No
13 M 91 1 Morganella morgnaii No Urinary No 1 Effective No 1 Yes
14 M 81 3 Serratia marcescens No Gastrointestinal No 0 Ineffective No 3 No
15 M 69 2 Serratia marcescens No Skin and soft tissues Yes 0 Effective Yes No change No
16 M 77 4 Serratia marcescens No Gastrointestinal Yes 0 Ineffective No No change No
17 F 79 3 Serratia marcescens No NA No 1 Ineffective No No change Yes
18 M 54 2 Serratia marcescens No Vascular No 0 Effective No 10 Yes
(b)
Patient Sex Age Number of Comorbidities Enterobacterales Species Suspected Site Associated with BSI Healthcare-Associated Infection qPitt Score for Severity Initial Empirical Therapy Clinical Stability after 48 h Delay until Reassessment of Therapy in Case of Switch (days) In-Hospital Death
1 M 65 2 Enterobacter cloacae Urinary No 0 Effective Yes No change No
2 M 83 3 Escherichia coli Pulmonary No 2 Ineffective No 2 Yes
3 M 88 4 Enterobacter cloacae Urinary No 0 Ineffective No 5 No
4 M 89 2 Enterobacter cloacae Vascular Yes 0 Effective Yes 2 No
5 F 63 2 Escherichia coli Urinary No 0 Ineffective No 2 No
6 F 83 2 Klebsiella pneumoniae Urinary Yes 1 Effective Yes No change No
7 F 88 3 Escherichia coli Gastrointestinal No 2 Ineffective Yes 4 No
8 F 78 2 Escherichia coli Urinary No 0 Ineffective Yes 5 No

ESCPM: Enterobacter sp., Serratia marcescens, Citrobacter freundii, Providencia sp., Morganella morganii; ESBL: extended-spectrum beta-lactamase; BSI: bloodstream infection; AST: antibiotic sensitivity testing.